The FDA approved the fourth natural food color additive this year, but how can you avoid the artificial dyes still out there?

Pierre Fabre leads global development of tab-cel, an innovative therapy for EBV+ PTLD, with ongoing trials and potential FDA ...

Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

Gardenia (genipin) blue is the fourth natural food color additive the FDA has approved this year, but how is it made?

Bayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...

What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood ...

Bayer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending a label extension for Eylea 8 mg ...

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease ...

The FDA has denied Regeneron's bid to stretch the administration of high-dose Eylea from a maximum frequency of every 16 weeks to every 24 weeks.

According to the company, the CRL does not identify any safety or efficacy issues with aflibercept 8 mg, but the FDA did not agree with the company’s proposal to add additional extended dosing ...